For Lorraine Simpson, a Chicago-based sales representative with Professional Detailing Inc., there are no downsides to working for a contract sales organization. "I'm telling you, it's wonderful!" she said. "But the perception is that in contractual work, you don't work as hard and you're not on the same level. In my opinion, we work just as hard."
For Lorraine Simpson, a Chicago-based sales representative with Professional Detailing Inc., there are no downsides to working for a contract sales organization. "I'm telling you, it's wonderful!" she said. "But the perception is that in contractual work, you don't work as hard and you're not on the same level. In my opinion, we work just as hard."
Challenge is built into the contract situation itself. "We want to see the contracts get renewed," Simpson explained. "So it's to our advantage to really work hard to prove to the company that we can increase sales."
"The expectations are just the same - you see a certain number of physicians, do sales promotions ... your managers and evaluations are the same. The only difference is that you usually don't have the entertainment budgets that other companies have," she said. "So therefore, your evening and weekend programs are less."
Simpson got her start as a full-time, "noncontract" sales representative with Syntex Laboratories in the early 1980s. After taking a break from her sales career and having a son, Simpson came back to work - this time as a contract rep. With an active family life, social and community calendar, art and gardening, the less hectic evening schedule is a plus.
"What I like is the diversity of all of it - learning a new product, meeting different people," Simpson said. And her company has helped. "I have probably done more interesting things with PDI than I've ever been able to do before." As for the old, "noncontract" days? Simpson said, "I haven't looked back since!"
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.